Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study
- PMID: 23920020
- PMCID: PMC3974341
- DOI: 10.1161/STROKEAHA.113.000947
Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study
Abstract
Background and purpose: Exposure to vascular risk factors has a gradual deleterious effect on brain MRI and cognitive measures. We explored whether a pattern of these measures exists that predicts stroke and Alzheimer disease (AD) risk.
Methods: A cognitive battery was administered to 1679 dementia and stroke-free Framingham offspring (age, >55 years; mean, 65.7±7.0) between 1999 and 2004; participants were also free of other neurological conditions that could affect cognition and >90% also had brain MRI examination. We related cognitive and MRI measures to risks of incident stroke and AD ≤10 years of follow-up. As a secondary analysis, we explored these associations in The Framingham Heart Study original cohort (mean age, 67.5±7.3 and 84.8±3.3 years at the cognitive assessment and MRI examination, respectively).
Results: A total of 55 Offspring participants sustained strokes and 31 developed AD. Offspring who scored <1.5 SD below predicted mean scores, for age and education, on an executive function test, had a higher risk of future stroke (hazard ratio [HR], 2.27; 95% confidence interval [CI], 1.06-4.85) and AD (HR, 3.60; 95% CI, 1.52-8.52); additional cognitive tests also predicted AD. Participants with low (<20 percentile) total brain volume and high (>20 percentile) white matter hyperintensity volume had a higher risk of stroke (HR, 1.97; 95% CI, 1.03-3.77 and HR, 2.74; 95% CI, 1.51-5.00, respectively) but not AD. Hippocampal volume at the bottom quintile predicted AD in the offspring and original cohorts (HR, 4.41; 95% CI, 2.00-9.72 and HR, 2.37; 95% CI, 1.12-5.00, respectively). A stepwise increase in stroke risk was apparent with increasing numbers of these cognitive and imaging markers.
Conclusions: Specific patterns of cognitive and brain structural measures observed even in early aging predict stroke risk and may serve as biomarkers for risk prediction.
Keywords: Alzheimer disease; cognition; magnetic resonance imaging; stroke.
Figures


Comment in
-
Alzheimer disease and stroke: Cognitive and neuroimaging predictors of AD and stroke.Nat Rev Neurol. 2013 Nov;9(11):605-6. doi: 10.1038/nrneurol.2013.215. Epub 2013 Oct 22. Nat Rev Neurol. 2013. PMID: 24145371 No abstract available.
Similar articles
-
Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study.J Alzheimers Dis. 2016 Jul 14;53(4):1597-608. doi: 10.3233/JAD-160229. J Alzheimers Dis. 2016. PMID: 27540965
-
Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.JAMA Netw Open. 2019 May 3;2(5):e193359. doi: 10.1001/jamanetworkopen.2019.3359. JAMA Netw Open. 2019. PMID: 31074810 Free PMC article.
-
Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study.Stroke. 2010 Apr;41(4):600-6. doi: 10.1161/STROKEAHA.109.570044. Epub 2010 Feb 18. Stroke. 2010. PMID: 20167919 Free PMC article.
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease.Adv Exp Med Biol. 2019;1205:25-53. doi: 10.1007/978-3-030-31904-5_3. Adv Exp Med Biol. 2019. PMID: 31894568 Review.
Cited by
-
Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study.Liver Int. 2019 Sep;39(9):1713-1721. doi: 10.1111/liv.14161. Epub 2019 Jun 26. Liver Int. 2019. PMID: 31155826 Free PMC article.
-
Arterial wall function is associated with cognitive performance primarily in elderly with type 2 diabetes.J Alzheimers Dis. 2015;44(2):687-93. doi: 10.3233/JAD-141197. J Alzheimers Dis. 2015. PMID: 25352451 Free PMC article.
-
Gait Patterns in Patients with Hereditary Spastic Paraparesis.PLoS One. 2016 Oct 12;11(10):e0164623. doi: 10.1371/journal.pone.0164623. eCollection 2016. PLoS One. 2016. PMID: 27732632 Free PMC article.
-
Genetic variation underlying cognition and its relation with neurological outcomes and brain imaging.Aging (Albany NY). 2019 Mar 4;11(5):1440-1456. doi: 10.18632/aging.101844. Aging (Albany NY). 2019. PMID: 30830859 Free PMC article.
-
Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.JAMA Neurol. 2018 Jan 1;75(1):97-104. doi: 10.1001/jamaneurol.2017.3229. JAMA Neurol. 2018. PMID: 29159396 Free PMC article.
References
-
- Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–e215. - PubMed
-
- Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011;377:1019–1031. - PubMed
-
- Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, et al. Dementia after stroke: the Framingham Study. Stroke. 2004;35:1264–1268. - PubMed
-
- Jin YP, Di Legge S, Ostbye T, Feightner JW, Hachinski V. The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimers Dement. 2006;2:171–178. - PubMed
-
- Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke. 2004;35:2620–2622. - PubMed
Publication types
MeSH terms
Grants and funding
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- R01 NS017950/NS/NINDS NIH HHS/United States
- R01 AG016495/AG/NIA NIH HHS/United States
- U01 HL096917/HL/NHLBI NIH HHS/United States
- N01 HC025195/HC/NHLBI NIH HHS/United States
- AG08122/AG/NIA NIH HHS/United States
- R01 AG008122/AG/NIA NIH HHS/United States
- P30AG013846/AG/NIA NIH HHS/United States
- HL93029/HL/NHLBI NIH HHS/United States
- AG031287/AG/NIA NIH HHS/United States
- AG16495/AG/NIA NIH HHS/United States
- U01HL 096917/HL/NHLBI NIH HHS/United States
- R01 AG031287/AG/NIA NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- AG033193/AG/NIA NIH HHS/United States
- R01 HL093029/HL/NHLBI NIH HHS/United States
- NS17950/NS/NINDS NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- R01 AG033193/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials